Literature DB >> 15257110

Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4.

Duncan B Hughes, Stephen R Grobmyer, Murray F Brennan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257110     DOI: 10.1097/00006676-200408000-00013

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  3 in total

1.  Clinical and radiologic resolution of IgG 4 normal, nonoperatively diagnosed lymphoplasmacytic sclerosing pancreatitis (LPSP) after initiation of steroid therapy.

Authors:  Stephen W Behrman; Shamim M Moinuddin; Donald S Gravenor
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

2.  Autoimmune pancreatitis and concurrent small lymphocytic lymphoma: not just a coincidence?

Authors:  Tad Kim; Stephen R Grobmyer; Lisa R Dixon; Robert W Allan; Steven N Hochwald
Journal:  J Gastrointest Surg       Date:  2008-05-28       Impact factor: 3.452

3.  Prevalence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head.

Authors:  M J van Heerde; K Biermann; P E Zondervan; G Kazemier; C H J van Eijck; C Pek; E J Kuipers; H R van Buuren
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.